Peril in perishing pericytes

J Natl Cancer Inst. 2015 Aug 21;107(10):djv254. doi: 10.1093/jnci/djv254. Print 2015 Oct.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Breast Neoplasms / blood supply
  • Breast Neoplasms / drug therapy
  • CD11b Antigen / metabolism
  • Carcinoma, Lewis Lung / drug therapy
  • Carcinoma, Lewis Lung / pathology
  • Cell Hypoxia
  • Female
  • Gene Silencing
  • Humans
  • Interleukin-6 / genetics
  • Melanoma, Experimental / drug therapy
  • Melanoma, Experimental / pathology
  • Myeloid Cells
  • Necrosis
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Neoplasms / pathology*
  • Neovascularization, Pathologic / drug therapy*
  • Pericytes / drug effects*
  • Pericytes / immunology*
  • Pericytes / pathology
  • Proto-Oncogene Proteins c-sis / metabolism*
  • Receptors, Chemokine / metabolism

Substances

  • Angiogenesis Inhibitors
  • CD11b Antigen
  • Gr-1 protein, mouse
  • Interleukin-6
  • Proto-Oncogene Proteins c-sis
  • Receptors, Chemokine